VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ARAYAccuray Incorporated
$0.29$35M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksARAYCash Flow

Accuray Incorporated (ARAY) Cash Flow Statement

21Y historyFree accessUpdated daily

Liquidity is under pressure as evidenced by a negative 6.8% free cash flow margin in 2026Q3 and a dwindling cash balance of $38.1 million.

ARAY Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05
Cash from Operations-19.12M2.86M-11.9M15.54M-2.4M38.51M-1.47M-29.64M18.33M-380K33.54M-16.73M346K-66.18M-38.28M12.4M-5.07M-8.05M-17.99M11.6M25.5M18.02M
Operating CF Margin %-0.62%-2.67%3.47%-0.56%9.72%-0.38%-7.08%4.53%-0.1%8.41%-4.41%0.09%-20.94%-9.35%5.58%-2.29%-3.44%-8.55%8.26%48.22%80.51%
Operating CF Growth %-1049.89%124.03%-176.61%747.46%-106.23%2721.65%95.04%-261.7%4923.95%-101.13%300.43%-4936.13%100.52%-72.88%-408.63%344.49%36.95%55.27%-255.12%-54.53%41.58%-
Net Income-46.13M-1.59M-15.54M-9.28M-5.35M-6.31M3.83M-16.43M-23.9M-29.58M-25.5M-40.21M-35.45M-116.51M-78.45M-27.11M2.84M609K5.38M-5.62M-33.69M-25.19M
Depreciation & Amortization7.51M6.15M5.91M4.53M5.51M6.39M7.54M10.49M9.73M18.04M18.3M19.49M20.56M25.56M32.59M7.57M7.12M6.65M7.69M6.25M3.81M2.08M
Stock-Based Compensation6.71M10.2M9.48M10.05M10.6M9.33M8.15M10.6M12.29M13.63M12.64M13.93M11.31M8.22M8.46M13.37M10.23M15.46M16.9M12.63M00
Deferred Taxes80K156K1.4M456K1.78M-114K353K-86K30K-268K-404K664K92K947K1.69M524K260K705K-16.72M553K00
Other Non-Cash Items13.44M6.15M8.77M5.16M7.65M21.42M538K12.5M10.13M10.28M12.54M11.32M10.89M26.63M5.72M1.7M684K3.1M17.82M-335K9M9.14M
Working Capital Changes-736K-18.2M-21.92M4.62M-22.6M7.8M-21.88M-46.72M10.04M-12.49M15.97M-21.93M-7.07M-11.03M-8.29M16.36M-26.21M-34.57M-49.05M-1.88M46.4M31.98M
Change in Receivables12.61M13.36M-15.83M18.49M-12.52M5.24M19.03M-46.16M7.22M-15.73M22.95M-8.33M-14.79M10.86M-9.16M8.7M-2.45M-2.82M-23.92M-936K00
Change in Inventory-15.11M-9.11M-4M-6.86M-22.86M1.69M-23.18M-14.16M-8.69M7.67M-10.5M-21.09M-8.34M-5.15M11.93M-4.32M244K-9.68M-10.43M-8.77M-4.35M-2.29M
Change in Payables6.78M-18.67M17.36M2.85M11.68M-3.98M-6.77M9.46M2M2.19M2.4M-1.82M-1.06M-1.14M-21.43M10.66M-5.36M1.83M-1.18M9.53M00
Cash from Investing-14.33M-8.52M-3.6M-12.68M-4.72M-2.4M-3.73M-4.31M17.77M17.82M8.26M3.69M8.49M-121.62M-12.15M31.42M10.53M1.87M-133.42M-7.51M-12.45M-12.27M
Capital Expenditures-6.72M-4.27M-3.6M-12.61M-4.72M-2.32M-3.56M-4.31M-6.61M-5.36M-8.07M-10.45M-11.93M-15.36M-10.77M-4.02M-5.13M-4.23M-5.03M-7.23M-13.6M-6.25M
CapEx % of Revenue1.57%0.93%0.81%2.82%1.1%0.59%0.93%1.03%1.63%1.4%2.02%2.75%3.23%4.86%2.63%1.81%2.31%1.81%2.39%5.15%25.71%27.93%
Acquisitions00000-79K00333K333K000-3.86M-1.38M-70.27M00000-5.61M
Investments----------------------
Other Investing-7.61M-4.25M0-67K0-389K-170K0-333K-333K16.33M14.13M20.42M-232K0004.3M-4.83M1K1.16M-153K
Cash from Financing-2.49M-4.25M-3.95M-2.11M-15.37M-28.8M26.7M28.47M-27.45M-54.54M-757K5.89M8.38M117.92M100.55M5.6M3.84M5.78M-16.25M172.86M-2.25M1.56M
Debt Issued (Net)9.9M7.5M-6M-3.87M-19M-17.41M24.45M24.55M-31.55M-56.91M-1.77M0-417K110.46M96.1M00000-3M0
Equity Issued (Net)1.29M1.63M2.25M2.2M3.89M-14.42M03.93M003.85M6.55M9.05M7.46M4.45M5.6M2.03M4.11M-16.67M172.31M748K1.56M
Dividends Paid0000000000000000000000
Share Repurchases00000-14.08M00-293K-1.42M00000000-23.98M0-21K-177K
Other Financing-13.68M-13.38M-198K-447K-258K3.03M2.24M04.1M2.37M-2.83M-660K-260K0001.81M1.67M419K553K00
Net Change in Cash-35.79M-8.26M-20.81M1.05M-28.05M8.29M21.73M-5.36M8.3M-36.9M40.22M-12.79M19.03M-70.19M47.6M50.47M8.6M-101K-167.89M176.97M10.83M7.3M
Free Cash Flow-28.95M-5.66M-15.51M2.86M-7.12M36.19M-5.2M-33.95M11.72M-5.74M25.47M-27.18M-11.59M-81.53M-49.05M8.38M-10.2M-12.28M-23.02M4.37M11.9M11.77M
FCF Margin %-6.76%-1.24%-3.47%0.64%-1.66%9.13%-1.36%-8.11%2.9%-1.5%6.39%-7.16%-3.14%-25.8%-11.99%3.77%-4.6%-5.26%-10.94%3.11%22.5%52.58%
FCF Growth %-264.88%63.48%-642.51%140.16%-119.66%796.4%84.69%-389.64%304.07%-122.55%193.72%-134.6%85.79%-66.24%-685.23%182.14%16.9%46.66%-627.11%-63.31%1.16%-
FCF per Share-0.23-0.06-0.160.03-0.080.39-0.06-0.390.14-0.070.32-0.35-0.15-1.11-0.690.14-0.17-0.21-0.380.140.740.82
FCF Conversion (FCF/Net Income)0.63x-1.80x0.77x-1.67x0.45x-6.10x-0.38x1.80x-0.77x0.01x-1.32x0.42x-0.01x0.64x0.53x-0.46x-1.79x-13.21x-3.34x-2.06x-0.76x-0.72x
Interest Paid09.74M10.52M9.85M7.46M11.89M12.33M9.76M9.19M9.93M10.34M7.21M8.21M3.75M1.88M000223K000
Taxes Paid03.87M1.75M2.15M1.4M1.87M2.81M2.19M1.46M4.46M1.03M3.18M2.5M2M1.2M1.39M60K194K1.26M000

Key Metrics

Growth RegimeDecelerating
ProfitabilityNegative
Balance SheetStrained
Cash FlowDeteriorating
Top Statement Risk

Capital intensity and liquidity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Earnings Quality Remains Highly Volatile

According to the provided financial data, the relationship between net income and operating cash flow is erratic, evidenced by a 2025Q4 OCF/NI ratio of -8.64, which suggests that reported earnings are frequently decoupled from the actual cash generation capabilities of the underlying radiotherapy business model.

The significant divergence between net income and operating cash flow indicates that non-cash items and working capital fluctuations are masking the true cash-generating potential of the firm. Investors should monitor this volatility, as it implies that the company's accounting earnings may not be a reliable proxy for its ability to fund operations internally.

Free Cash Flow Trajectory Weakens

As reported in the quarterly cash flow statements, Accuray has struggled to maintain positive free cash flow, with a -6.8% FCF margin in 2026Q3, reflecting a persistent inability to generate surplus cash after accounting for necessary capital expenditures and the company's high fixed-cost operating structure.

The consistent failure to achieve sustained positive free cash flow suggests that the business model remains structurally dependent on external financing or cash reserves to bridge operational gaps. This trend warrants further investigation into whether the company can reach a scale where cash inflows from service contracts consistently exceed the cash outflows required for product development.

Working Capital Swings Obscure Liquidity

Based on the reported figures, working capital changes have been highly inconsistent, ranging from a $21.1 million inflow in 2026Q1 to an $18.0 million outflow in 2025Q4, which suggests that the timing of customer payments and inventory management remains a primary source of cash flow instability.

These sharp swings in working capital appear to be driven by the lumpy nature of system installations and the associated milestone-based payment structures. Such variability makes it difficult to forecast short-term liquidity, as the company's cash position is highly sensitive to the timing of project completions and regulatory approvals.

Capital Intensity Remains Relatively Low

Data from the last ten quarters indicates that Accuray maintains a low capital intensity, with CapEx/Revenue ratios frequently hovering near 1%, as noted in the 2026Q3 figure of 0.4%, suggesting that the company is not currently investing heavily in new physical manufacturing capacity.

While the low capital intensity may appear to preserve cash, it may also indicate a lack of investment in the infrastructure needed to drive future growth or improve manufacturing efficiency. Analysts should consider whether this low level of spending is sufficient to maintain the competitive relevance of the CyberKnife and Radixact platforms against better-capitalized peers.

ARAY — Frequently Asked Questions

Quick answers to the most common questions about buying ARAY stock.

How much cash does Accuray Incorporated (ARAY) generate from operations?

Accuray Incorporated (ARAY) generated $2.9M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Accuray Incorporated's free cash flow?

Accuray Incorporated (ARAY) reported negative free cash flow of $5.7M in 2025, indicating capital requirements exceeded cash from operations.

What is Accuray Incorporated's capital expenditure (CapEx)?

Accuray Incorporated (ARAY) spent $4.3M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.